At Bristol Myers Squibb (BMS), we're not just about doing a job. We are about transforming lives through groundbreaking work in biotechnology and healthcare. We are proud to announce an exciting opportunity to be a part of our dynamic biotech sector at RayzeBio, a key player in cancer treatment innovations and a wholly owned subsidiary of BMS.
Positioned at the forefront of oncology research, RayzeBio, headquartered in San Diego, CA, aims to become a global leader in radiopharmaceuticals targeting solid tumors. Our entrepreneurial team focuses on innovative cancer treatments, including our leading asset, RYZ101, currently in Phase 3 testing.
The Sr. Manager of Biostatistical Programming at RayzeBio will spearhead the development of clinical study deliverables and timelines, manage programming activities of study vendors, and play a crucial role in supporting internal company requests.
At BMS, we understand the importance of balance and flexibility. We offer a comprehensive range of benefits and programs that support our team's health, growth, and well-being. Interested in transforming patient lives and advancing your career with a leader in biotechnology? Visit our career page at to learn more and apply.
BMS values diversity and is committed to creating an inclusive environment where all employees can thrive. We are dedicated to promoting diversity in clinical trials and the broader healthcare community. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status.
If this opportunity at RayzeBio excites you, but your experience doesn't line up perfectly with every qualification in the job description, we encourage you to apply anyway. You might be just the candidate we’re looking for
Don’t miss the chance to be part of a powerful team transforming lives through innovative medical science. Apply now to take your career to the next level with Bristol Myers Squibb and RayzeBio.